Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did you read the article amc?
The article in fact tells the opposite story, looks like approval will come faster. Why? Because The National Cancer Institute is starting to take some of the workload concerning reviewing these tests.
On Tuesday's call, Becker said FDA Commissioner Stephen Hahn told him and members of his association that the National Cancer Institute (NCI) would start reviewing tests that are on the market to see if they obtain correct results.
More than 90 companies have informed the FDA that they're selling antibody tests. Becker said it's not clear how many tests the NCI will be reviewing to see if they work.
"I am concerned that some of the antibody tests that are on the market that haven't gone through the FDA scientific review may not be as accurate as we'd like them to be,"
If they can't stand a day of -35% they better run away altogether, they're not worth the long uptrend we're about to see in coming months.
Another $7,5M purchase order from the state owned enterprise and we leave the moaners in the dust.
A lot of moaning and crying on the board today.
$14M loan from a state owned Chinese bank will take care of this, no worries. Excellent entries today. You either believe the CEO that they will pay the remaining debt with cash EOM or you don't. Now is the time to bail if you don't.
Nice ask slappin'.
ABMC Mkt Cap $8,5M , DECN Mkt Cap $40M. ABMC is undervalued, lack of PR has a stake in it, either way, patience is a virtue!
Low floater, high volatility.
Red to green here in a while.
A T-trade is a transaction that went through during trading hours but only got registrated afterwards. It happens all the time, doesn't mean per se that there is dilution going on.
KWBT Most Read #13.
In general $0,018 - $0,025 is a tough nut to crack, shouldn't be a problem in the coming days with these underlying fundamentals.
That's not dumping, small 60K, 20K, 10K orders. MM games, low floater, lack of shares.
Gearing up, very promising for a EOD rocket!
Going to be fun EOD!
A cup forming here intradaily and on the daily too.
Let them play, one of these days won't be sitting at this level anymore.
OTC shake sure made that ask look thin now. Next volume wave sends us to $0,03.
Looking really healthy here.
Fake wall right there.
Not that many shares in the $0,20'ss!
Thin all the way to $0,03.
Excitment for growth the company is undergoing.
Yes, big week ahead for serological test companies, very big. Fauci giving the big green light. We're sitting on gold here.
Yeah, why risk $300k worth of test kit material if it were not to be FDA approved, doesn't make any sense.
$300K money flow on a Thursday EOW is promising.
Dollars soon.
a cooperation agreement with Huaxialitai Co., Ltd., a China state-owned enterprise that has an enormous fertilizer market channel throughout the Country of China.
Great article, seems to me the logistical and decreased production output related to chemical fertilizers bodes well for KWBT.
With a float of 14M... the news that 44k kits were send to Florida is like sending the MM's and shorts a warm and friendly pre holiday signal that the PPS is about to explode. With the news that these kits have been delivered and FDA approval now a matter of one or few business days away is like... all hence on deck we're most definitly going to explode any minute now...
KWBT one of the best investments on the OTC for Q2-Q3, ridiculous cheap right now.
End of April. Might have some shareholders waiting to recoup their investment at the $0,05 range. Will just be a little bump in the road heading into dimeland.
If you want to know the importance of testing workers, check Germany as a case study. Out of all Western European countries they're doing relatively well and that's all attributable to one thing: they're testing a whole lot more than other countries. America is starting to adapt the same strategy, right now it's the only way to tackle the COVID-19 crisis. Forget about FFP masks or other PPE, it's all about test kits from companies with good fundamentals and undervalued market cap. ABMC has got all the ducks in a row.
There's a reason why this company doesn't put out any fluff PR's, no SEC suspension here. There is no convertible debt, huge inside ownership and a low float. They're busy manufactering hundred thousand of test kits. And it's not a one time thing, they'll be manufactering these in spring, summer and the remainder of the year. 7,5M market cap is crazy low. Once they have the seal of approval by the FDA she's going to fly, with new orders on the horizon it's definitly heading to paper land. Not going to stop at 1$ either, that's still only a 35M market cap.
$ABMC way ahead of the curve in regards to the antibodies tests. I bet they're already working on another mega order that we don't know of.
And Jean Neff gets a 7K slice of the 35M pie for a telephone meeting.
One giant cup about to get filled!
They got a loan from PSBC:
After 12 years of dedicated efforts, the Bank has become an important player in the market with marked influence. In 2019, it is ranked 22nd in The Banker’s Top 1000 World Banks 2019 in terms of tier 1 capital. It has been rated A+ and A1 by Fitch and Moody’s respectively, which is the same as China’s sovereignty credit rating; it has been rated A by Standard & Poor’s, which is the highest rating among the large state-owned commercial banks.
Still kicking myself in the face a little bit after wanting to buy in on Thursday after reading the PR from Wednesday that they will pay in cash the convertible debt by the end of April... I hesitated on buying on Thursday at the open, before I knew $0,014 was gone, one hour later it was already $0,02 and early at noon there were not many shares visible on LVL2. 5M-10M volume Monday morning and it's sitting at $0,03. Honestly I wouldn't mind if it went back to $0,016 on Monday, would like to double down on my stack of KWBT shares. It's so obvious that it is a sleepig giant waking up from a long period of downtrend. These last two PR's are setting the tone for what lies ahead. It's no coincidence that the founder is back in business as CEO and the company suddently not in need for notes anymore and getting a big loan from a state owned bank. It's harvest time!
Boooyaaa! Right up our alley.